Discussion
Our study described a multidisciplinary approach to prevent the development of hypothermia in extremely preterm low-weight infants undergoing transcatheter PDA device closure. With the implementation of multiple measures, we were able to achieve more than 50% reduction in the development of transient intraoperative hypothermia at the start of the procedure, which was statistically significant. Also, we were able to achieve a statistically significant improvement in mean core body temperature at the beginning of the procedure, thus reflecting a smaller percentage of temperature drop during patient transport, monitor placement, induction of anaesthesia, patient positioning and surgical draping. The results have proven that our measures to provide better thermal care were successful.
Small observational studies have shown increased mortality among preterm patients with hypothermia at birth.5 Thus, maintaining a normal perioperative core body temperature is a goal of optimal anaesthetic care. We implemented multiple interventions to ameliorate thermal care in our susceptible infants.
A recent retrospective observational study by Hubbard et al6 on anaesthetic management of catheter-based PDA closure in neonates weighing <3 kg indicates that the prevalence of postoperative hypothermia is 3%. Similar approaches to thermal care were used in our study, such as transportation in prewarmed transport incubators, limiting cold exposure by placement of intravenous catheter and endotracheal tube in the NICU, forced air warming device, as well as increasing ambient air temperature. Note that hypothermia is defined in the latter study as a body temperature <36°C. In our study, we defined hypothermia as a temperature <36.5°C, according to the WHO definition.1 After our interventions, postoperative temperature was >36°C in all patients except for only one.
Moreover, we observed a decrease in the anaesthesia and procedure interval time between the two groups. Since transcutaneous PDA closure in very low-weight infants is a relatively new and technically challenging treatment, we attribute the shortening in anaesthesia and procedure time to a steep learning curve among our interventional cardiologists as well as efforts to reduce the overall time spent at a remote location. Radiation dosage was decreased over time, thus reducing the radiation hazard in this vulnerable population. This was attributed to technical improvement among the proceduralists.
Although our initiative was successful, our long-term goal is to completely eliminate perioperative hypothermia in these susceptible patients. One of the major hurdles faced was providers’ compliance to changing their behaviour. Transporting a ventilated infant in a closed incubator can be of utmost challenge to some providers. We were able to overcome this difficulty by holding meetings to address people’s concerns, stressing on the importance of maintaining a thermal-neutral environment during transport and providing education to increase familiarity with transport incubators for easy accessibility in case of an emergency. We believe that regular monitoring of thermal care, appreciation and feedback to the staff, as well as awareness among newly hired providers are crucial in maintaining the implemented measures. The checklist on thermoregulation improvement (online supplemental file 1) is now accessible to all providers and added to the anaesthesia protocol for cardiac catheterisation procedures at our institution.
We believe that our project is generalisable to other hospitals. It is based on team awareness of the dangers of hypothermia and the simple methods of heat conservation in infants, including procedure room warming, forced air warming device, minimal body surface exposure, careful anaesthesia planning and transport in a neutral thermal environment. This project demonstrated the importance of a protocol development in order to achieve adequate care in this vulnerable patient population.
Our project had some limitations. First, this was a retrospective study. Second, the number of patients included in the study was limited due to the study’s short total period (14 months) and the fact that this novel technique is reserved for a failed conservative or pharmacological management of PDA at our institution. Third, sustainability data beyond February 2020 were beyond the scope of this study. However, our interventions were mostly implemented in August and September 2019 and we observed continued improvement through February 2020. The intervention seems to have translated to sustained practice changes, but sustainability audit should also be made. Fourth, due to the small number of cases and the distant interval separating them, a plan-do-study-act strategy was not adapted in our study. In contrast, a bundle of changes were concomitantly implemented and hence we were unable to determine the effect of each individual intervention on improved thermal care. Moreover, a lack of process measures limits the correlation between the interventions and the outcomes of the study.